Heterotransplantability of human cell lines derived from leukemia and lymphomas into immunologically tolerant rats.
D000818:Animals; D001853:Bone Marrow / Q000276:immunology; D002051:Burkitt Lymphoma / Q000276:immunology* / Q000473:pathology; D002460:Cell Line; D006801:Humans; D007108:Immune Tolerance; D007244:Infectious Mononucleosis / Q000276:immunology / Q000473:pathology; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007945:Leukemia, Lymphoid / Q000276:immunology / Q000473:pathology; D007951:Leukemia, Myeloid / Q000276:immunology* / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000473:pathology; D008198:Lymph Nodes / Q000276:immunology / Q000637:transplantation; D016403:Lymphoma, Large B-Cell, Diffuse / Q000276:immunology; D008722:Methods; D009368:Neoplasm Transplantation; D051381:Rats; D014181:Transplantation Immunology; D014183:Transplantation, Heterologous